|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
27 June 2016 |
|
Main ID: |
NCT00617721 |
|
Date of registration:
|
05/02/2008 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Markers of Defective Membrane Remodelling in Scott-like Syndromes
|
|
Scientific title:
|
Defect in Cell Stimulation and Unexplained hemorrhagesMarkers Related to Membrane Remodelling in the Prognosis Scott-like Syndormes |
|
Date of first enrolment:
|
June 2008 |
|
Target sample size:
|
29 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT00617721 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Family-Based, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
|
Martinique
| | | | | | |
|
Contacts
|
|
Name:
|
Lélia GRUNEBAUM, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hôpitaux Universitaires de Strasbourg |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with unexplained provoked hemorrhages (surgery, tooth extraction, birth …),
and associated with reduced prothrombin consomption (residual prothrombine in serum >
à 5%).
- Family members of the patients defined above, with or without unexplained hemorrhages
(symptomatic or not).
- Patient's approval based on detailed information given by the pratician
Exclusion Criteria:
- Patients with primary hemostasis defect or defective blood coagulation factor(s)
possibly explaining the bleeding disorder.
- Anémia,
- patients known to be affected by Factor V New York .
- Patients enrolled in a previous clinical study, the exclusion period of which is not
yet completed. - Collaboration to the study rejected by the patient
- Patients that are not registered for medical care social insurance.
Age minimum:
2 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Unexplained Isolated Provoked Hemorrhages
|
|
Familial Bleeding Disorder
|
|
Scott Syndrome
|
|
Intervention(s)
|
|
Other: Blood withdrawal
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|